Association study of N-methyl-D-aspartate receptor subunit 2B (GRIN2B) polymorphisms and schizophrenia symptoms in the Han Chinese population

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yang, Yongfeng ^a,b   Li, Wenqiang ^b   Zhang, Hongxing ^b   Yang, Ge ^b   Wang, Xiujuan ^b   Ding, Minli ^b   Jiang, Tianzi ^a   Lv, Luxian ^b  

^a UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR;

ADULT; AGE; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRIN2B GENE; HAN CHINESE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARANOID SCHIZOPHRENIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; SCHIZOPHRENIA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84932604138     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125925     Document Type: Article

References (52)

1. Owen MJ, Craddock N, O'Donovan MC. Schizophrenia: genes at last? Trends Genet. 2005; 21: 518-525. PMID: 16009449
2. Schultz SK, Andreasen NC. Schizophrenia. Lancet. 1999; 353: 1425-1430. PMID: 10227239
3. 'b'Kendler KS, Eaves LJ. Psychiatric Genetics(Review of Psychiatry) American Psychiatric Association. Arlington,VA; 2005.
4. Gottesman II. Schizophrenia genesis: the origins of madness. New York: Freeman; 1991.
5. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009; 373: 234-239. doi: 10.1016/S0140-6736(09)60072-6 PMID: 19150704
6. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, et al. Molecular genetics of schizophrenia collaboration. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008; 40: 1053-1055. doi: 10.1038/ng.201 PMID: 18677311
7. Williams HJ, Owen MJ, O'Donovan MC. New findings from genetic association studies of schizophrenia. J Hum Genet. 2009; 54: 9-14. doi: 10.1038/jhg.2008.7 PMID: 19158819
8. Yue WH, Wang HF, Sun LD, Tang FL, Liu ZH, Zhang HX, et al. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet. 2011; 43: 1228-1231. doi: 10.1038/ng.979 PMID: 22037552
9. Shi YY, Li ZQ, Xu Q, Wang T, Li T, Shen JW, et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet. 2011; 43: 1224-1227. doi: 10.1038/ng.980 PMID: 22037555
10. Javitt DC. Negative schizophrenic symptomatology and the phencyclidine (PCP) model of schizophrenia. Hillside J. Psychiatry. 1987; 9: 12-35. PMID: 2820854
11. Tsai G, Coyle JT. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol. 2002; 42: 165-179. PMID: 11807169
12. Sodhi M, Wood KH, Meador-Woodruff J. Role of glutamate in schizophrenia: integrating excitatory avenues of research. Expert Rev Neurother. 2008; 8: 1389-1406. doi: 10.1586/14737175.8.9.1389 PMID: 18759551
13. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001; 158: 1367-1377. PMID: 11532718
14. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994; 17: 31-108. PMID: 8210177
15. Nakanishi S, Masu M. Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct. 1994; 23: 319-348. PMID: 7919785
16. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 1991; 354: 31-37. PMID: 1834949
17. Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci Biobehav Rev. 2010; 34: 958-977. doi: 10.1016/j.neubiorev.2010.01.002 PMID: 20060416
18. Quin SY, Zhao X, Pan YX, Liu JH, Feng GY, Fu JC, et al. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur J Hum Genet. 2005; 13: 807-814. PMID: 15841096
19. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet. 2010; 42: 1021-1026. doi: 10.1038/ng.677 PMID: 20890276
20. Myers RA, Casals F, Gauthier J, Hamdan FF, Keebler J, Boyko AR, et al. A population genetic approach to mapping neurological disorder genes using deep resequencing. PLoS Genet. 2011; 7: e1001318. doi: 10.1371/journal.pgen.1001318 PMID: 21383861
21. Williams HJ, Georgieva L, Dwyer S, Kirov G, Owen MJ, O'Donovan MC. Absence of de novo point mutations in exons of GRIN2B in a large schizophrenia trio sample. Schizophr Res. 2012; 141: 274-276. doi: 10.1016/j.schres.2012.08.024 PMID: 22986046
22. Martucci L, Wong AH, De Luca V, Likhodi O, Wong GW, King N, et al. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels. Schizophr Res. 2006; 84: 214-221. PMID: 16549338
23. Di Maria E, Gulli R, Begni S, De Luca A, Bignotti S, Pasini A, et al. Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. Am J Med Genet B Neuropsychiatr Genet. 2004; 128B: 27-29. PMID: 15211626
24. Iwayama Y, Hashimoto K, Nakajima M, Toyota T, Yamada K, Shimizu E, et al. Analysis of correlation between serumd-serine levels and functional promoter polymorphisms of GRIN2A and GRIN2B genes. Neuroscience Letters. 2006; 394: 101-104. PMID: 16266783
25. White T, Ho BC, Ward J, O'Leary D, Andreasen NC. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects. Biol Psychiatry. 2006; 60: 463-471. PMID: 16566898
26. Andreasen NC, Flaum M, Arndt S. The comprehensive assessment of symptoms and history (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992; 49: 615-623. PMID: 1637251
27. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261-276. PMID: 3616518
28. Kim JH, Kim SY, Lee J, Oh KJ, Kim YB, Cho ZH. Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Res. 2012; 197: 285-289. doi: 10.1016/j.psychres.2011.10.006 PMID: 22364933
29. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 2006; 34: W635-641. PMID: 16845089
30. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263-265. PMID: 15297300
31. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003; 19: 149-150. PMID: 12499305
32. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000; 155: 945-959. PMID: 10835412
33. Gaspar PA, Bustamante ML, Silva H, Aboitiz F. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. J Neurochem. 2009; 111: 891-900. doi: 10.1111/j.1471-4159.2009.06325.x PMID: 19686383
34. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the szGene database. Nat Genet. 2008; 40: 827-834. doi: 10.1038/ng.171 PMID: 18583979
35. Li DW, He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med. 2007; 9: 4-8. PMID: 17224684
36. Lewis DA, Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat Med. 2006; 12: 1016-1022. PMID: 16960576
37. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005; 10: 40-68. PMID: 15263907
38. Miyatake R, Furukawa A, Suwaki H. Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol Psychiatry. 2002; 7: 1101-1106. PMID: 12476325
39. Hong CJ, Yu YW, Lin CH, Cheng CY, Tsai SJ. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr Genet. 2001; 11: 219-222. PMID: 11807413
40. Ohtsuki T, Sakurai K, Dou H, Toru M, Yamakawa-Kobayashi K, Arinami T. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Molecular Psychiatry. 2001; 6: 211-216. PMID: 11317224
41. Ripke S, Sanders AR, Kendler KS, Levinson DF. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011; 43: 969-976. doi: 10.1038/ng.940 PMID: 21926974
42. de Quervain DJ, Papassotiropoulos A. Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. Proc Natl Acad Sci U S A. 2006; 103: 4270-4274. PMID: 16537520
43. Jablensky A, Morar B, Wiltshire S, Carter K, Dragovic M, Badcock JC, et al. Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. Genes Brain Behav. 2011; 10: 410-417. doi: 10.1111/j.1601-183X.2011.00679.x PMID: 21281445
44. Austin J. Schizophrenia: an update and review. J Genet Counselling. 2005; 14: 329-340. PMID: 16195940
45. Muesser KT, McGurk SR. Schizophrenia. Lancet. 2004; 363: 2063-2072. PMID: 15207959
46. Ocklenburg S, Arning L, Hahn C, Gerding WM, Epplen JT, Güntürkün O, et al. Variation in the NMDA receptor 2B subunit gene GRIN2B is associated with differential language lateralization. Behav Brain Res. 2011; 225: 284-289. doi: 10.1016/j.bbr.2011.07.042 PMID: 21827795
47. Bakker PR, Al Hadithy AF, Amin N, van Duijn CM, van Os J, van Harten PN. Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 TagSNPs in 7 candidate genes: a prospective study. PLoS One. 2012; 7: e50970. doi: 10.1371/journal.pone.0050970 PMID: 23226551
48. Cai J, Zhang W, Yi ZH, Lu WH, Wu ZG, Chen J, et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology (Berl). 2013; 230: 49-55. doi: 10.1007/s00213-013-3137-2 PMID: 23660601
49. Breier A. Cognitive deficit in schizophrenia and its neurochemical basis. Br J Psychiatry Suppl. 1999; 37: 16-18. PMID: 10211135
50. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, et al. Genetic enhancement of learning and memory in mice. Nature. 1999; 401: 63-69. PMID: 10485705
51. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009; 23: 315-336. doi: 10.1037/a0014708 PMID: 19413446
52. Li WQ, Yang YY, Lin JT, Wang S, Zhao JY, Yang G, et al. Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Han Chinese population. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 44: 290-295. doi: 10.1016/j.pnpbp.2013.04.003 PMID: 23583772